Combined treatment of IL-1α and TNF-α potentiates the antitumour effect of hyperthermia

References

• Avebrook B. J., Yamamoto R. S., Ulich T. R., Jeffes E. W. B., Masunak I., Granger G. A. Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin. Journal of Clinical Immunology 1987; 7: 333–340
   PubMedGoogle Scholar
• Babbs C. F., Dewitt D. P., Voorhees W. D., McCaw J. S., Chan P. C. Theoretical feasibility of vasodilator enhanced local tumor heating. European Journal of Cancer and Clinical Oncology 1982; 18: 1137–1146
   PubMedGoogle Scholar
• Balkwill F. R. Tumor necrosis factor. British Medical Bulletin 1989; 45: 389–400
   PubMed Web of Science ®Google Scholar
• Belardell F., Proietti E., Ciolli V., Sestili P., Carpetilli G., van Vito M., Ferretti A., Woodrow D., Boraschi D., Podio F. Interleukin 1β induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor αβ. International Journal of Cancer 1989; 44: 117–123
   Google Scholar
• Braunschweiger P. G., Johnson C. S., Kuma N., Ord V., Furmanski P. Antitumor effects of recombinant human Interleukin 1 in RIF-1 and PancO2 solid tumors. Cancer Research 1988; 48: 6011–6016
   PubMed Web of Science ®Google Scholar
• Braunschweiger P. G., Johnson C. S., Kumar N., Ord V., Furmanski P. The effect of adrenalectomy and dexamethasone on interleukin-1α induced responses in RIF-1 tumors. British Journal of Cancer 1990a; 61: 9–13
   PubMed Web of Science ®Google Scholar
• Braunschweiger P. G., Kumar N., Conastantinidis I., Wehrle J. P., Glickson J. D., Johnson C. S., Furmanski P. Potentiation of interleukin 1α-mediated antitumor effects by ketoconazole. Cancer Research 1990b; 50: 4709–4717
   PubMed Web of Science ®Google Scholar
• Butler L. D., Layman N. K., Cain R. L., Riedl P. E., Mohler K. M., Bobbitt J. L., Belagajie R., Sharp J., Bendele A. M. Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immuno-pharmacological intervention. Clinical Immunology and Immunopathology 1989; 53: 400–421
   PubMedGoogle Scholar
• Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P. C., Pan Y. C. E., Olander J. V., Connolly D. T., Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cells and monocyte procoagulant activity, and promotes monocyte migration. Journal of Experimental Medicine 1990; 172: 1535–1545
   PubMed Web of Science ®Google Scholar
• Constantinidis L., Braunschweiger P. G., Wehrle J. P., Kumar N., Johnson C. S., Furmanski P., Glickson J. D. 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin-1α on the bioenergetics of RIF-1 tumors. Cancer Research 1989; 49: 6379–6382
   PubMed Web of Science ®Google Scholar
• Horsman M. R., Christinsen K. L., Overgaard J. Hydralazine-induced enhancement of hyperthermia damage in a C3H mammary carcinom in vivo. International Journal of Hyperthermia 1989; 5: 123–136
   PubMed Web of Science ®Google Scholar
• Jain R. K., Shah S. A., Finney P. L. Continuous noninvasive monitoring of pH and temperature in rat Walker 256 carcinoma during normoglycemia and hyperglycemia. Journal of the National Cancer Institute 1984; 73: 429–436
   PubMedGoogle Scholar
• Jain R. K., Ward-Hartley K. Tumor blood flow: characterization, modifications and role in hyperthermia. IEEE Transactions, Sonics Ultrasonics 1984; SU-31: 504–526
   Google Scholar
• Johnson C. W., Chang M. J., Braunschweiger P. G., Furnanski P. Acute hemorrhagic necrosis of tumors induced by interkeukin-1α: effects independent of tumor necrosis factor. Journal of the National Cancer Institute 1991; 83: 842–848
   PubMed Web of Science ®Google Scholar
• Kallinowski F., Schaefer C., Tyler G., Vaupel P. In vivo targets of recombinant human tumor necrosis factor-α: blood flow, oxygen consumption and growth of isotransplanted rat tumors. British Journal of Cancer 1989; 60: 555–560
   PubMed Web of Science ®Google Scholar
• Kluge M., Elger B., Engel T., Schaefer C., Seega J., Vaupel P. Acute effects of tumor necrosis factor α or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors. Cancer Research 1992; 52: 2167–2173
   PubMedGoogle Scholar
• Lin J. C., Song C. W. Effects of hydralazine on the blood flow in RIF-1 tumors and normal tissues of mice. Radiation Research 1990; 124: 171–177
   PubMedGoogle Scholar
• Maier J. A. M., Statuto M., Ragnotti G. Endogenous interleukin-1α must be transported to the nucleus to exert its activity in human endothelial cells. Molecular and Cellular Biology 1994; 14: 1845–1851
   PubMed Web of Science ®Google Scholar
• Manda T., Shimonura K., Mukumoto S., Kobayashi K., Mizota T., Hirai O., Matsumoto S., Oku T., Nishigaki F., Mori J., Kikuchi H. Recombinant human tumor necrosis factor-α: evidence of indirect mode of antitumor activity. Cancer Research 1987; 47: 3703–3711
   Google Scholar
• Mantovani A., Bussolino F., Dejana E. Cytokine regulation of endothelial cell function. FASEB Journal 1992; 6: 2591–2599
   PubMed Web of Science ®Google Scholar
• Movat H. Z. Tumor necrosis factor and interleukin 1: role in acute inflammation and microvascular injury. Journal of Laboratory and Clinical Medicine 1987; 110: 668–681
   PubMed Web of Science ®Google Scholar
• Pober J., Cotran R. S. Cytokines and endothelial cell biology. Physiology Review 1990; 70: 427–451
   PubMed Web of Science ®Google Scholar
• Reinhold H. S., Endrich B. Tumor microcirculation as a target for hyperthermia. International Journal of Hyperthermia 1986; 2: 111–137
   PubMedGoogle Scholar
• Song C. W. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Research 1984; 44: 4721s–4730s
   PubMed Web of Science ®Google Scholar
• Song C. W., Kang M. S., Rhee J. G., Levitt S. H. Vascular damage and delayed cell death in tumors after hyperthermia. British Journal of Cancer 1980; 41: 309–312
   PubMed Web of Science ®Google Scholar
• Song C. W., Lin J. C., Lyons J. C. Antitumour effect of interleukin-1α in combination with hyperthermia. Cancer Research 1993; 53: 324–328
   PubMedGoogle Scholar
• Tomasovic S. P., Lu S., Klostergaard J. Comparative In vivo studies of the potentiation of tumor necrosis factor (TNF)-α, TNF-β, and TNF-SAM2 cytotoxicity by hyperthermia. Journal of Immunotherapy 1992; 11: 85–92
   PubMed Web of Science ®Google Scholar
• Urano M., Mantoya V., Booth A. Effect of hyperglycemia on the thermal response of murine normal and tumor tissues. Cancer Research 1983; 43: 453–455
   PubMed Web of Science ®Google Scholar
• Vaupel P., Kallinowski F., Kluge M. Pathophysiology of tumors in hyperthermia. Recent Result Cancer Research 1988; 107: 65–75
   PubMedGoogle Scholar
• Von Ardenne M. Selective multiphase cancer therapy. Conceptual aspects and experimental basis. Advanced Pharmacology and Chemotherapy 1972; 10: 339–380
   PubMedGoogle Scholar
• Watanabe N., Niitsu Y., Umeno H., Kuriyama H., Neda H., Yamakuchi N., Maeda M., Urushizaki I. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Research 1988; 48: 2179–2183
   PubMed Web of Science ®Google Scholar